高派息
Search documents
亚翔集成跌2.02%,成交额1.11亿元,主力资金净流出101.00万元
Xin Lang Zheng Quan· 2025-11-11 05:52
Core Viewpoint - Yaxin Integrated Technology has experienced a significant stock price increase of 92.69% year-to-date, despite a recent decline of 1.43% over the past five trading days [1] Company Overview - Yaxin Integrated Technology (Suzhou) Co., Ltd. was established on February 28, 2002, and went public on December 30, 2016. The company specializes in high-tech electronic industries, including IC semiconductors and optoelectronics, as well as cleanroom engineering services for various sectors [2] - The main revenue sources for Yaxin Integrated include cleanroom system integration engineering (94.53%), other engineering services (3.13%), equipment sales (1.44%), and other income (0.90%) [2] - The company is categorized under the construction decoration industry, specifically in specialized engineering [2] Financial Performance - For the period from January to September 2025, Yaxin Integrated reported a revenue of 3.109 billion yuan, a year-on-year decrease of 29.63%. However, the net profit attributable to shareholders increased by 0.78% to 442 million yuan [2] - The company has distributed a total of 920 million yuan in dividends since its A-share listing, with 693 million yuan distributed over the past three years [3] Shareholder Information - As of October 31, 2025, the number of shareholders increased by 4.01% to 11,400, with an average of 18,686 circulating shares per shareholder, a decrease of 3.85% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 7.4891 million shares, a decrease of 186,400 shares from the previous period. Meanwhile, Guangfa Small Cap Growth Mixed Fund increased its holdings by 739,200 shares to 2.9746 million shares [3]
鸿富瀚跌2.01%,成交额1.36亿元,主力资金净流出584.17万元
Xin Lang Zheng Quan· 2025-11-11 03:12
Core Viewpoint - Hongfuhuan's stock price has shown significant growth this year, but recent trading data indicates a slight decline in share price and net outflow of funds, suggesting potential volatility in the market [1][2]. Group 1: Stock Performance - Hongfuhuan's stock price has increased by 83.50% year-to-date, with a 3.45% rise in the last five trading days, 25.14% in the last 20 days, and 64.93% in the last 60 days [2]. - As of November 11, the stock price was reported at 91.88 CNY per share, with a total market capitalization of 8.269 billion CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Hongfuhuan achieved a revenue of 650 million CNY, reflecting a year-on-year growth of 7.87%. However, the net profit attributable to shareholders decreased by 25.79% to 81.6556 million CNY [2]. - The company has distributed a total of 291 million CNY in dividends since its A-share listing, with 231 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 6.02% to 11,700, while the average circulating shares per person increased by 6.40% to 4,062 shares [2]. - Notably, the major shareholder list has changed, with the Dazheng Zhongzheng 360 Internet + Index A fund exiting the top ten circulating shareholders [3].
新华保险跌2.01%,成交额5.96亿元,主力资金净流出1040.01万元
Xin Lang Zheng Quan· 2025-11-11 03:06
Core Viewpoint - Xinhua Insurance's stock price has shown a significant increase of 40.93% year-to-date, despite a recent decline of 2.01% on November 11, with a current trading price of 67.24 CNY per share [1]. Financial Performance - For the period from January to September 2025, Xinhua Insurance reported a net profit of 32.857 billion CNY, marking a year-on-year growth of 58.88% [2]. - The company has cumulatively distributed dividends of 35.939 billion CNY since its A-share listing, with 13.913 billion CNY distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 34.15% to 81,900, while the average number of circulating shares per person decreased by 25.55% to 25,555 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 36.448 million shares, a decrease of 24.0617 million shares from the previous period [3]. Market Activity - On November 11, the trading volume reached 596 million CNY, with a turnover rate of 0.42% and a total market capitalization of 209.758 billion CNY [1]. - The net outflow of main funds was 10.4001 million CNY, with large orders accounting for 32.65% of purchases and 31.75% of sales [1].
绿联科技跌2.06%,成交额5622.85万元,主力资金净流出475.90万元
Xin Lang Zheng Quan· 2025-11-11 02:27
Core Viewpoint - Ugreen Technology's stock price has experienced fluctuations, with a year-to-date increase of 71.29% but a recent decline of 9.23% over the last five trading days [1] Company Overview - Ugreen Technology, established on March 16, 2012, is located in Longhua District, Shenzhen, Guangdong Province, and specializes in the research, design, production, and sales of 3C consumer electronics [2] - The company's main business segments include charging products (37.01% of revenue), transmission products (26.64%), audio and video products (16.34%), storage products (10.75%), mobile peripheral products (7.88%), and others (1.33%) [2] - As of September 30, 2025, Ugreen Technology reported a revenue of 6.364 billion yuan, a year-on-year increase of 47.80%, and a net profit attributable to shareholders of 467 million yuan, up 45.08% year-on-year [2] Stock Performance - As of November 11, Ugreen Technology's stock price was 63.72 yuan per share, with a market capitalization of 26.438 billion yuan [1] - The stock has seen a trading volume of 56.2285 million yuan and a turnover rate of 0.53% [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on January 9, where it recorded a net buy of -24.6681 million yuan [1] Shareholder Information - As of September 30, 2025, Ugreen Technology had 8,578 shareholders, a decrease of 10.42% from the previous period, with an average of 19,235 circulating shares per shareholder, an increase of 454.77% [2][3] - The top ten circulating shareholders include notable funds, with the largest increase in holdings seen in 富国中小盘精选混合A/B [3]
百傲化学涨2.02%,成交额1.16亿元,主力资金净流入367.88万元
Xin Lang Cai Jing· 2025-11-11 02:24
Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 108.74%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 11, Baiao Chemical's stock price was 32.28 yuan per share, with a market capitalization of 22.797 billion yuan [1]. - The stock has seen a trading volume of 1.16 billion yuan and a turnover rate of 0.51% on the same day [1]. - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on August 28 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 12.51% to 24,000, while the average circulating shares per person decreased by 11.12% to 29,483 shares [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Dividend Distribution - Since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion yuan in dividends, with 722 million yuan distributed over the past three years [3].
信立泰涨2.00%,成交额1.76亿元,主力资金净流入4946.00元
Xin Lang Zheng Quan· 2025-11-10 06:24
Core Insights - The stock price of Xinlitai has increased by 95.79% year-to-date, with a recent trading price of 59.58 CNY per share as of November 10 [1] - The company reported a revenue of 3.241 billion CNY for the first nine months of 2025, reflecting an 8% year-on-year growth, and a net profit of 581 million CNY, up 13.93% [2] - Xinlitai has distributed a total of 7.204 billion CNY in dividends since its A-share listing, with 1.649 billion CNY distributed over the past three years [3] Company Overview - Xinlitai Pharmaceutical Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on November 3, 1998, with its stock listed on September 10, 2009 [1] - The company's main business includes the research, production, and sales of pharmaceuticals and medical devices, with revenue composition as follows: 81.69% from formulations, 8.54% from devices, 7.17% from raw materials, and 2.59% from others [1] Shareholder and Market Activity - As of September 30, 2025, Xinlitai had 25,200 shareholders, an increase of 4.87% from the previous period, with an average of 44,249 circulating shares per shareholder, down 4.64% [2] - The top ten circulating shareholders include notable funds, with China Europe Medical Health Mixed A being the second-largest shareholder, increasing its holdings by 1.0162 million shares [3]
毕得医药涨2.07%,成交额2313.78万元,主力资金净流入318.58万元
Xin Lang Cai Jing· 2025-11-10 05:59
Core Viewpoint - Bid Pharma's stock price has shown a significant increase of 50.29% year-to-date, with a current market capitalization of 6.597 billion yuan, indicating strong investor interest and performance in the pharmaceutical sector [1][2]. Financial Performance - For the period from January to September 2025, Bid Pharma achieved a revenue of 979 million yuan, representing a year-on-year growth of 20.67%. The net profit attributable to shareholders was 120 million yuan, reflecting a substantial increase of 42.79% compared to the previous year [2]. - The company has distributed a total of 258 million yuan in dividends since its A-share listing [3]. Stockholder Information - As of September 30, 2025, the number of shareholders for Bid Pharma decreased by 7.64% to 3,493, while the average number of circulating shares per person increased by 8.27% to 12,377 shares [2]. - The top ten circulating shareholders include notable institutional investors, with China Europe Medical Health Mixed A being the second-largest shareholder, increasing its holdings by 20.07% [3]. Market Activity - On November 10, Bid Pharma's stock rose by 2.07%, trading at 72.59 yuan per share with a total transaction volume of 23.1378 million yuan. The stock has experienced a slight decline of 1.71% over the past five trading days but has shown a positive trend over longer periods [1].
双汇发展涨2.02%,成交额1.86亿元,主力资金净流入1759.28万元
Xin Lang Cai Jing· 2025-11-10 03:45
Core Viewpoint - The stock of Shuanghui Development has shown a positive trend with a year-to-date increase of 8.79%, reflecting strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Shuanghui Development reported a revenue of 446.53 billion yuan, representing a year-on-year growth of 1.23% [2]. - The net profit attributable to shareholders for the same period was 39.59 billion yuan, marking a year-on-year increase of 4.05% [2]. Stock Market Activity - As of November 10, Shuanghui Development's stock price was 26.72 yuan per share, with a market capitalization of 925.76 billion yuan [1]. - The stock experienced a trading volume of 1.86 billion yuan and a turnover rate of 0.20% [1]. - The net inflow of main funds was 17.59 million yuan, with significant buying activity from large orders [1]. Shareholder Information - As of October 31, the number of shareholders for Shuanghui Development was 157,800, a decrease of 2.54% from the previous period [2]. - The average number of circulating shares per shareholder increased by 2.60% to 21,952 shares [2]. Dividend Distribution - Since its A-share listing, Shuanghui Development has distributed a total of 644.95 billion yuan in dividends, with 156.26 billion yuan distributed over the past three years [3]. Major Shareholders - As of September 30, 2025, the top circulating shareholder was Hong Kong Central Clearing Limited, holding 76.67 million shares, an increase of 14.07 million shares from the previous period [3]. - China Securities Finance Corporation remained stable in its holdings, while new shareholders included Southern S&P China A-share Large Cap Dividend Low Volatility ETF and E Fund CSI Major Consumer ETF [3].
晋控煤业涨2.05%,成交额3.36亿元,主力资金净流出1782.32万元
Xin Lang Cai Jing· 2025-11-10 03:36
Core Viewpoint - Jin Energy Holdings Co., Ltd. has experienced a significant increase in stock price and trading volume, indicating strong market interest despite a decline in revenue and profit for the year [1][2]. Group 1: Stock Performance - As of November 10, Jin Energy's stock price rose by 2.05% to 16.90 CNY per share, with a trading volume of 336 million CNY and a turnover rate of 1.21%, resulting in a total market capitalization of 28.286 billion CNY [1]. - Year-to-date, the stock price has increased by 30.86%, with a 12.37% rise over the last five trading days, 13.35% over the last 20 days, and 17.69% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Jin Energy reported operating revenue of 9.325 billion CNY, a year-on-year decrease of 16.99%, and a net profit attributable to shareholders of 1.277 billion CNY, down 40.65% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 6.083 billion CNY in dividends, with 3.640 billion CNY distributed over the past three years [2]. Group 3: Shareholder Structure - As of October 20, 2025, the number of shareholders increased to 58,000, with an average of 28,856 circulating shares per person, a decrease of 4.40% from the previous period [2]. - The second-largest circulating shareholder is the Guotai CSI Coal ETF, holding 33.2232 million shares, an increase of 2.024 million shares from the previous period [2].
老白干酒涨2.04%,成交额2.50亿元,主力资金净流入694.80万元
Xin Lang Zheng Quan· 2025-11-10 03:33
Core Viewpoint - The stock of Laobai Gan Liquor has shown fluctuations, with a recent increase of 2.04% to 17.01 CNY per share, despite a year-to-date decline of 16.78% [1] Financial Performance - For the period from January to September 2025, Laobai Gan Liquor reported a revenue of 3.33 billion CNY, a year-on-year decrease of 18.53% [2] - The net profit attributable to shareholders for the same period was 400 million CNY, down 28.04% year-on-year [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Laobai Gan Liquor was 180,300, a decrease of 5.69% from the previous period [2] - The average number of tradable shares per shareholder increased by 6.04% to 5,043 shares [2] Dividend Distribution - Laobai Gan Liquor has cumulatively distributed dividends of 2.15 billion CNY since its A-share listing, with 1.19 billion CNY distributed over the last three years [3] Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder is the China Securities White Wine Index A, holding 45.27 million shares, unchanged from the previous period [3] - The third-largest circulating shareholder is the Wine ETF, which increased its holdings by 7.82 million shares to 22.99 million shares [3]